These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27059620)

  • 21. Ferumoxytol MR Angiography versus Duplex US for Vascular Mapping before Arteriovenous Fistula Surgery for Hemodialysis.
    Stoumpos S; Tan A; Hall Barrientos P; Stevenson K; Thomson PC; Kasthuri R; Radjenovic A; Kingsmore DB; Roditi G; Mark PB
    Radiology; 2020 Oct; 297(1):214-222. PubMed ID: 32692301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular artifact mimicking thrombosis on MR imaging using ferumoxytol as a contrast agent in abdominal vascular assessment.
    Fananapazir G; Marin D; Suhocki PV; Kim CY; Bashir MR
    J Vasc Interv Radiol; 2014 Jun; 25(6):969-76. PubMed ID: 24630749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
    Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
    Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases.
    Bashir MR; Mody R; Neville A; Javan R; Seaman D; Kim CY; Gupta RT; Jaffe TA
    J Magn Reson Imaging; 2014 Jul; 40(1):113-8. PubMed ID: 24130008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermodality feature fusion combining unenhanced computed tomography and ferumoxytol-enhanced magnetic resonance angiography for patient-specific vascular mapping in renal impairment.
    Yoshida T; Nguyen KL; Shahrouki P; Quinones-Baldrich WJ; Lawrence PF; Finn JP
    J Vasc Surg; 2020 May; 71(5):1674-1684. PubMed ID: 31734117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging applications for ferumoxytol as a contrast agent in MRI.
    Bashir MR; Bhatti L; Marin D; Nelson RC
    J Magn Reson Imaging; 2015 Apr; 41(4):884-98. PubMed ID: 24974785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-resolution 3D volumetric contrast-enhanced MR angiography with a blood pool agent (ferumoxytol) for diagnostic evaluation of pediatric brain arteriovenous malformations.
    Iv M; Choudhri O; Dodd RL; Vasanawala SS; Alley MT; Moseley M; Holdsworth SJ; Grant G; Cheshier S; Yeom KW
    J Neurosurg Pediatr; 2018 Sep; 22(3):251-260. PubMed ID: 29882734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.
    Toth GB; Varallyay CG; Horvath A; Bashir MR; Choyke PL; Daldrup-Link HE; Dosa E; Finn JP; Gahramanov S; Harisinghani M; Macdougall I; Neuwelt A; Vasanawala SS; Ambady P; Barajas R; Cetas JS; Ciporen J; DeLoughery TJ; Doolittle ND; Fu R; Grinstead J; Guimaraes AR; Hamilton BE; Li X; McConnell HL; Muldoon LL; Nesbit G; Netto JP; Petterson D; Rooney WD; Schwartz D; Szidonya L; Neuwelt EA
    Kidney Int; 2017 Jul; 92(1):47-66. PubMed ID: 28434822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pictorial review on abdominal applications of ferumoxytol in MR imaging.
    Kordbacheh H; Baliyan V; Parakh A; Wojtkiewicz GR; Hedgire S; Harisinghani MG
    Abdom Radiol (NY); 2019 Oct; 44(10):3273-3284. PubMed ID: 31378828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MR Imaging of the Mesenteric Vasculature.
    Collins JD
    Radiol Clin North Am; 2020 Jul; 58(4):797-813. PubMed ID: 32471545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular Imaging With Ferumoxytol as a Contrast Agent.
    Hope MD; Hope TA; Zhu C; Faraji F; Haraldsson H; Ordovas KG; Saloner D
    AJR Am J Roentgenol; 2015 Sep; 205(3):W366-73. PubMed ID: 26102308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ferumoxytol-enhanced MRI in the peripheral vasculature.
    Lehrman ED; Plotnik AN; Hope T; Saloner D
    Clin Radiol; 2019 Jan; 74(1):37-50. PubMed ID: 29731126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MR venography using an intravascular contrast agent: results from a multicenter phase 2 study of dosage.
    Larsson EM; Sundén P; Olsson CG; Debatin J; Duerinckx AJ; Baum R; Hahn D; Ebner F
    AJR Am J Roentgenol; 2003 Jan; 180(1):227-32. PubMed ID: 12490510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferumoxytol-enhanced magnetic resonance angiography provides comparable vascular conspicuity to CT angiography in dogs with intrahepatic portosystemic shunts.
    Wilson S; Culp WTN; Wisner ER; Cissell DD; Finn JP; Zwingenberger AL
    Vet Radiol Ultrasound; 2021 Jul; 62(4):463-470. PubMed ID: 33634935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A three-dimensional gadolinium-enhanced MR venography technique for imaging central veins.
    Thornton MJ; Ryan R; Varghese JC; Farrell MA; Lucey B; Lee MJ
    AJR Am J Roentgenol; 1999 Oct; 173(4):999-1003. PubMed ID: 10511166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal transplant imaging using magnetic resonance angiography with a nonnephrotoxic contrast agent.
    Bashir MR; Jaffe TA; Brennan TV; Patel UD; Ellis MJ
    Transplantation; 2013 Jul; 96(1):91-6. PubMed ID: 23680931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ferumoxytol use as an intravenous contrast agent for magnetic resonance angiography.
    Stabi KL; Bendz LM
    Ann Pharmacother; 2011 Dec; 45(12):1571-5. PubMed ID: 22045905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of ferumoxytol with gadolinium as contrast agents for the diagnostic magnetic resonance imaging of osteomyelitis.
    Langsjoen J; Neuwelt A; Eberhardt S; Mlady G; Shukla U; Murali S; Pizanis C; Sillerud LO
    Magn Reson Imaging; 2020 Sep; 71():45-54. PubMed ID: 32439428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ferumoxytol-enhanced MR Angiography for Vascular Access Mapping before Transcatheter Aortic Valve Replacement in Patients with Renal Impairment: A Step Toward Patient-specific Care.
    Nguyen KL; Moriarty JM; Plotnik AN; Aksoy O; Yoshida T; Shemin RJ; Suh WM; Finn JP
    Radiology; 2018 Jan; 286(1):326-337. PubMed ID: 29040038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent.
    Li W; Tutton S; Vu AT; Pierchala L; Li BS; Lewis JM; Prasad PV; Edelman RR
    J Magn Reson Imaging; 2005 Jan; 21(1):46-52. PubMed ID: 15611942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.